These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19270384)

  • 1. Development, characterization, and evaluation of a fusion protein of a novel glucagon-like peptide-1 (GLP-1) analog and human serum albumin in Pichia pastoris.
    Gao Z; Bai G; Chen J; Zhang Q; Pan P; Bai F; Geng P
    Biosci Biotechnol Biochem; 2009 Mar; 73(3):688-94. PubMed ID: 19270384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-step purification of a fusion protein of glucagon-like peptide-1 and human serum albumin expressed in pichia pastoris by an immunomagnetic separation technique.
    Chen J; Bai G; Cao Y; Gao Z; Zhang Q; Zhu Y; Yang W
    Biosci Biotechnol Biochem; 2007 Nov; 71(11):2655-62. PubMed ID: 17986790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, and characterization of recombinant human serum albumin fusion protein with two human glucagon-like peptide-1 mutants in Pichia pastoris.
    Dou WF; Lei JY; Zhang LF; Xu ZH; Chen Y; Jin J
    Protein Expr Purif; 2008 Sep; 61(1):45-9. PubMed ID: 18556214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues.
    Green BD; Gault VA; Mooney MH; Irwin N; Harriott P; Greer B; Bailey CJ; O'Harte FP; Flatt PR
    Biol Chem; 2004 Feb; 385(2):169-77. PubMed ID: 15101559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity.
    Deacon CF; Knudsen LB; Madsen K; Wiberg FC; Jacobsen O; Holst JJ
    Diabetologia; 1998 Mar; 41(3):271-8. PubMed ID: 9541166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris.
    Huang YS; Chen Z; Chen YQ; Ma GC; Shan JF; Liu W; Zhou LF
    J Pept Sci; 2008 May; 14(5):588-95. PubMed ID: 17994612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes.
    Kim YM; Lee SM; Chung HS
    BMB Rep; 2013 Dec; 46(12):606-10. PubMed ID: 24195794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for fusion expression and preparation of functional glucagon-like peptide-1 (GLP-1) analogue by introducing an enterokinase cleavage site.
    Liu Y; Ren L; Ge L; Cui Q; Cao X; Hou Y; Bai F; Bai G
    Biotechnol Lett; 2014 Aug; 36(8):1675-80. PubMed ID: 24737080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a glucagon-like peptide-1 analogue, as a therapeutic agent for type II diabetes, with enhanced bioactivity and increased N-terminal homogeneity in Pichia pastoris.
    Qian K; Li C; Gong X; Ndawula C; Qian J; Chen Y; Li H; Jin J
    Biotechnol Lett; 2015 Nov; 37(11):2229-35. PubMed ID: 26160109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice.
    Chung HS; Oh JY; Yoo SB; Lee SM; Cho HS
    Regul Pept; 2011 Oct; 170(1-3):1-3. PubMed ID: 21621561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-level expression of fusion protein GGH in Pichia pastoris GS115 by constructing a double plasmid co-expression system].
    Wang H; Dou W; Zhang X; Xu H; Xu Z
    Sheng Wu Gong Cheng Xue Bao; 2011 Jul; 27(7):983-9. PubMed ID: 22016981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of a potent, long-lasting recombinant human serum albumin-interferon α1 fusion protein expressed in Pichia pastoris.
    Tian S; Li Q; Yao W; Xu C
    Protein Expr Purif; 2013 Aug; 90(2):124-8. PubMed ID: 23748141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc fusion to glucagon-like peptide-1 inhibits degradation by human DPP-IV, increasing its half-life in serum and inducing a potent activity for human GLP-1 receptor activation.
    Kim DM; Chu SH; Kim S; Park YW; Kim SS
    BMB Rep; 2009 Apr; 42(4):212-6. PubMed ID: 19403044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity.
    John H; Maronde E; Forssmann WG; Meyer M; Adermann K
    Eur J Med Res; 2008 Feb; 13(2):73-8. PubMed ID: 18424366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
    Islam MS; Rahman SA; Mirzaei Z; Islam KB
    Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel DPP-IV-resistant analog of glucagon-like peptide-1 (GLP-1): KGLP-1 alone or in combination with long-acting PLGA microspheres.
    Gao Z; Tang Y; Chen J; Bai R; Zhang Q; Hou Y; Lu Y; Bai G
    Peptides; 2009 Oct; 30(10):1874-81. PubMed ID: 19647775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo.
    Wu YL; Huang J; Xu J; Liu J; Feng Z; Wang Y; Lai Y; Wu ZR
    Regul Pept; 2010 Sep; 164(2-3):83-9. PubMed ID: 20570598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris.
    Lei J; Guan B; Li B; Duan Z; Chen Y; Li H; Jin J
    Protein Expr Purif; 2012 Jul; 84(1):154-60. PubMed ID: 22609631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.
    Lee SH; Lee S; Youn YS; Na DH; Chae SY; Byun Y; Lee KC
    Bioconjug Chem; 2005; 16(2):377-82. PubMed ID: 15769092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.